Oncoprotein Function and Mechanisms in Breast Cancer Dynamics

Breast cancer dynamics are shaped by a network of oncoproteins that drive malignant transformation through aberrant regulation of cell proliferation, survival, metabolism and metastasis. Oncoproteins such as HER2, c-Myc and MDM2 act as master regulators of signalling pathways and transcriptional programmes. They frequently intersect with PI3K/AKT, MAPK and p53 networks to override tumour-suppressive barriers. Beyond classical kinases and transcription factors, emerging oncoproteins including HBXIP function as transcriptional coactivators, epigenetic modulators and metabolic regulators. These proteins can promote aerobic glycolysis through the Warburg effect, inhibit mitochondrial apoptosis and induce drug resistance by rewiring the mitochondrial cytochrome c–caspase axis. Crosstalk with microRNA clusters, histone modifiers and the tumour microenvironment further amplifies their impact on cancer cell plasticity and therapeutic evasion. Mechanistic insights into oncoprotein nuclear import, feedback loops and post-translational modifications reveal nodes for targeted intervention. As a result, oncoprotein modulation underpins the development of novel inhibitors and combination approaches, offering hope for more personalised and effective strategies against aggressive and therapy-resistant breast cancers.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Oncoprotein Function and Mechanisms in Breast Cancer Dynamics publication trend

The graph below shows the total number of articles in oncoprotein function and mechanisms in breast cancer dynamics across all publications each year (not limited to Nature Index journals).

Technical terms

Oncoprotein: A protein whose abnormal expression or activity drives malignant transformation and tumour progression.

Transcriptional coactivator: A factor that does not bind DNA directly but enhances gene transcription by interacting with transcription factors and chromatin modifiers.

Aerobic glycolysis: A metabolic shift in cancer cells favouring glucose fermentation to lactate despite the presence of oxygen, also known as the Warburg effect.

MicroRNA (miRNA): A small non-coding RNA that regulates gene expression post-transcriptionally by binding target mRNAs.

Feedback loop: A regulatory circuit in which a protein indirectly or directly influences its own expression or activity through downstream effectors.

References

1. The oncogenic role of HBXIP. Biomedicine & Pharmacotherapy (2020).
2. The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer. Oncotarget (2015).
3. The Oncoprotein HBXIP Modulates the Feedback Loop of MDM2/p53 to Enhance the Growth of Breast Cancer*. Journal of Biological Chemistry (2015).